Back My treatment worked and there is little or no cancer left No cancer after first line chemo Answer each question to find trials that best match your clinical situation. You can leave questions blank if you do not know the answer. This search will output a list of trials for which you may be eligible based on the criteria you enter. I want to enter information about my cancer and treatments I want to enter information about my genetic testing (e.g, BRCA) and/or tumor testing results I want to filter the trials based on location, phase of development, tumor genomic alteration, or drug name, category or target Phase: selectPhase 1Phase 1 with expansionPhase 1 with ovarian expansionPhase 2Phase 3 Drug Category: selectAngiogenesis InhibitorsAntibody Drug ConjugatesApoptosis InducersB-cell antigen receptor (BCR) Signaling Pathway InhibitorsCell Cycle InhibitorsChemotherapyChromatin Structure/Gene Expression RegulatorsDNA Damage Repair Pathway Inhibitors: ATM, ATR, DNA-PK, etcDNA Damage Repair Pathway Inhibitors: PARPGene TherapyGrowth Factor InhibitorsGrowth Factor Receptor InhibitorsHormonal TherapyImmunotherapy: Anti-Tumor AntibodiesImmunotherapy: BispecificsImmunotherapy: Cellular TherapyImmunotherapy: Checkpoint InhibitorsImmunotherapy: Immune Cell StimulatorsImmunotherapy: ImmunomodulatorsImmunotherapy: VaccinesOncolytic VirusesRadiotherapy: RadiationRadiotherapy: RadioimmunoconjugatesSignaling Pathway Inhibitors: HedgehogSignaling Pathway Inhibitors: Integrins-FAKSignaling Pathway Inhibitors: JAK-STATSignaling Pathway Inhibitors: NotchSignaling Pathway Inhibitors: PI3K-AKT-mTORSignaling Pathway Inhibitors: RAS-RAF-MEK-ERKSignaling Pathway Inhibitors: TGF-betaSignaling Pathway Inhibitors: WNT/Beta-catenin Drug Name: No preference No preference[225Ac]-FPI-1434[225Ac]-FPI-1966177Lu-FAP-22862141 V-1123ME-00610AB-1015AB248ABBV-367ABBV-CLS-484ABBV-CLS-579AbemaciclibAbexinostatABL503ABM-1310ABSK021ABSK061ACR-368ADA-011AdagrasibADCT-901ADG106ADG116ADG126ADP-A2M4CD8AfatinibAFM24AfuresertibAG01AGEN1571AGEN2373agenT-797AldesleukinAlectinibAlpelisibAlpha-DC1 vaccineALRN-6924AMG 193AMG 404AMG 794AMXI-5001AMXT 1501AN4005AnastrozoleAnlotinibanti-EGFR AbAnti-KRAS G12D mTCR PBLAnti-KRAS G12V mTCR PBLAOH1996ART0380ART4215ASCA101ASN004ASP1570ASP3082ASTX029ASTX727AtezolizumabATG-101ATLCAR.CD30ATRC-101ATRN-119AU-007Autologous nCTLsAutologous TILsAvapritinibAVB-001AvelumabAvutometinibAxatilimabAxitinibAza-TdCAZD5305AZD8205AZD9574AzenosertibBAL0891BalstilimabBAY2416964BAY2965501BAY3375968BB-1701BBP-398BDB018BDC-1001BelinostatBemarituzumabBerzosertibBevacizumabBexmarilimabBGB-15025BGB-24714BGB-3245BGB-A425BGB-B167BI 765179BI 907828BI-1206BinimetinibBintrafusp alfaBIO-106BirinapantBJ-001BJ-005BLU-222BMS-986288BMS-986406BMS-986408BMS-986442BNT141BNT142BNT151BNT152BNT153BortezomibBotensilimabBozitinibBT4780BT5528BT8009BTX-1188BTX-A51BuparlisibBusulfanCAB-CTLA-4CabozantinibCAL056 mesylateCamonsertibCAN1012CapecitabineCAR.B7-H3CarboplatinCBX-12CDX-1140CediranibCemiplimabCeralasertibCetuximabCF33-hNISCFI-402257CFI-402411CFT1946CFT8634CI-8993CisplatinCLN-619ClofarabineClostridium Novyi-NTCM24CMP-001CobimetinibColchicineCOM902CopanlisibCPO-100CrizotinibCRX100CS5001CT-0508CTX-471CUE-102CYC140CyclophosphamideCYT-0851D-1553D3S-001DabrafenibDasatinibDatopotamab deruxtecanDB-1303DB-1305DCBY02DCC-3116DDRiDebio 0123DECOY20DefactinibDenileukin diftitoxDF1001DF6002DF9001DFP-14927DinaciclibDK210 (EGFR)DocetaxelDostarlimabDovitinibDoxorubicinDS-6000aDS-9606aDSP107DurvalumabDZ-002E-602E7046Efineptakin alfaEflornithineELI-002ElimusertibELU001ElzovantinibEMB-02ENB003EncorafenibEnfortumab VedotinEntinostatEntrectinibEOS-448EP0031ERAS-007ERAS-601ErdafitinibEribulinErlotinibEtigilimabEtoposideEU101EverolimusEvorpaceptEzabenlimabFadraciclibFarletuzumab ecteribulinFF-10832 Gemcitabine LiposomeFF-10850 Topotecan LiposomeFludarabineFocused Ultrasound AblationFORE8394FS120FSHCER T cellsFT536FT538FulvestrantFutibatinibGavocabtagene autoleucelGDC-1971GDC-6036GedatolisibGemcitabineGEN-001GEN-1GEN1053GI-101GiredestrantGNX102GRN-300GS-1811GS-9716GSK3745417GSK4381562GSK6097608GunagratinibHB0025HB0036HCW9218HH2710HH2853HIPECHMBD-002hSTC810huCART-meso cellsHuMax-IL8HydroxychloroquineIACS-6274IBI322IcatolimabICT01IdasanutlinIDE397IGM-8444IK-930IL-12IMA203IMA203CD8IMC-002IMC-F106CIMGN151IMM-1-104IMP7068IMP9064IMSA101InavolisibINBRX-105INCAGN01949INCB099280INCB106385INCB123667Individual Patient TCR-Transduced PBLInfigratinibInupadenantINV-1120IO-108IO-202IpatasertibIPG7236IpilimumabIrinotecanIvosidenibJAB-21822JAB-2485JAB-3312JAB-8263JBI-802JDQ443JPZ815JSI-1187JZP341KB-0742KD033KIN-2787KIN-3248KSQ-4279KT-333KVA12123KZR-261Labvax 3(22)-23LapatinibLarotrectinibLBL-007LenvatinibLetrozoleLifirafenibLiposomal doxorubicinLisaftoclaxLM-108LN-145-S1LNS8801LorigerlimabLorlatinibLOXO-435Luveltamab tazevibulinLVGN3616LVGN6051LVGN7409LY3295668LY3410738LY3537982LYT-200M4344Maveropepimut-SM-CENKMCLA-145MDK-703MDNA11MetarrestinMetforminMethoxyamineMilademetanMinnelideMinoxidilMirdametinibMirvetuximab soravtansineMK-1084MK-1088MK-1484MK-4830MOv19-BBz CAR TMPT-0118MRG002MRG004AMRT-2359MRTX0902MRTX1133MRTX1719MT-5111MT-6402MTB-9655MVF-HER-2(597-626)-MVF-HER-2 (266-296) peptide vaccineMV-NISMV-NIS infected mesynchymal stem cellsnab-PaclitaxelNab-Paclitaxel/STI-3031nab-SirolimusNanrilkefusp alfaNavicixizumabNBTXR3NC410NC762NDI-101150NedisertibNelfinavir mesylateNemvaleukin alfaNeoantigen specific TCR-T cell drug product (Sleeping Beauty)NeoVaxNeratinibNerofeNG-350ANG-641NGM438NGM707NGM831NilotinibNiraparibNirogacestatNivolumabNIZ985NM21-1480NMS-03305293Nogapendekin alfaNP-G2-044NT219NTX-1088NUV-868NVL-520NVL-655NX-019NXP800NY-ESO-1 TCR transgenic T cells and NY-ESO-1 TCR/sr39TK transgenic stem cellsOBI-3424OBI-999OBT076OKI-179OlaparibOlvimulogene nanivacirepvecOMTX705ON 123300ONC201ONC-392OR2805OregovomabORIC-114OTX-2002OxaliplatinPaclitaxelPaclitaxel-loaded TPMPalbociclibPamiparibPARPiPaxalisibPazopanibPBI-200PC14586PD-1iPD-L1iPegcetacoplanPembrolizumabPemetrexedPertuzumabPF-07104091PF-07220060PF-07257876PF-07260437PF-07265807PF-07284892PF-07799544PF-07799933PHESGOPidnarulexPimasertibpING-hHER3FLPIPACPLX038P-MUC1C-ALLO1 CAR-T cellspoly ICLCPrexigebersen-APRGN-3005PRGN-3007PRO1184ProAgioPRT2527PRT3789PT01PT199PUR001PY159PY314PYX-201Q702Q901Radiation TherapyRBN-2397RBS2418REGN5668REGN7075RegorafanibRelacorilantRelatlimabRepotrectinibRetifanlimabrhIL-15RibociclibRiMO-301RintatolimodRLY-2608RLY-4008RMC-4630RMC-5552RMC-6236RMC-6291RNK05047RP1RP3RP-6306RSC-1255RucaparibRunimotamabRX108S095029Sacituzumab govitecanSAR443216SAR444200SAR444245SB 11285SEA-TGTSelected Young TILSelinexorSelpercatinibSenaparibSerabelisibSGN1SGN-ALPVSGN-B7H4VSGN-STNVSHetA2siRNA-EphA2-DOPCSirolimusSKL27969SL-172154SLC-3010Sleeping Beauty Transposed PBLSNK01SNX281SON-1010SOR-C13SotorasibSpartalizumabSRF114SRK-181ST-067STAR0602STC-15StenoparibSTI-6643STK-012STP707STX-478SunitinibSurgerySym021SYNB1891T3011TAC-001TAC01-HER2TACH101TAEK-VAC-HerByTAG72-CAR T cellsTaladegibTalazoparibTAS0953/HM06TBX-3400TC-510TCR-TTemozolomideTemsirolimusTemuterkibThermotherapyTILT-123TiragolumabTislelizumabTivozanibTJ-CD4BTNG908TNO155TopotecanToripalimabTORL-1-23TORL-2-307-ADCTORL-2-37-MABTOS-358TovorafenibTPX-4589TrametinibTransCon IL-2 β/γTransCon TLR7/8TrastuzumabTrastuzumab deruxtecanTrastuzumab emtansineTRE-515TremelimumabTRK-950TST003TST005TT-00420TT-816TTfieldsTTI-622TU2218TucatinibTulmimetostatTuvusertibTYRA-300UbamatamabUCT-01-097UCT-03-008Upifitamab rilsodotinValproic acidVandetanibVB10.NEOVCN-01VEGFR TKIVeliparibVemurafenibVenetoclaxVinorelbineVIP152VIP236VismodegibVMD-928Vobramitamab duocarmazineVT3989VudalimabWTX-124WTX-330XB002XL092XL102XmAb24306XmAb808XMT-1660XRD-0394XTX101XTX202XTX301YL-13027ZafirlukastZanidatamabZanidatamab zovodotinZB131ZeaxanthinZEN-3694ZenocutuzumabZilovertamab vedotinZimberelimabZoledronic acidZX-4081 Location: selectAlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWest VirginiaWisconsinWyoming Molecular Target: No preference No preference4-1BB (CD137)5T4 oncofetal AgA2a/bRA2aRA2RACSS2 (Acetyl-CoA Synthetase 2)AHR (aryl hydrocarbon receptor)AktAKT1-3ALKALPG/P (alkaline phosphatase germ-line/placental)Alpha v beta 3Alpha v beta3,5,6Alpha-V/Beta-3 integrinALPP (Alkaline phosphatase, placental)AMPKARAFArginineARK5AromataseAsparagineATMATRAURKAURKAAURKBAxlB7H3B7H4BclBcl-2bcr-ablBETBRAFBranched Lewis B/Lewis Y antigenBRD4BRD9BTLA (CD272)BTN1A1BTN3A (CD277)C3CA125CAPRIN-1CB2R (Cannabinoid type 2 receptor)CCR1CCR5CCR8CD163CD200R1CD205CD22CD27CD28CD3CD30CD32BCD39CD40CD46CD47CD73CD8CD93CD96CDH6CDKCDK1/2CDK2CDK2/5/9CDK4CDK4/6CDK5CDK7CDK9CEACAM1 (CD66a)CEACAM5 (CD66e)ChkCHK1/2CK1alphac-KitCLDN18.2 (Claudin 18.2)CLDN6 (Claudin 6)Clever-1/Stabilin-1c-MetCOX-2CRAFCRM1CSF1R (fms)CSP (Cancer Specific Plectin)CTLACTLA-4CXCRCXCR3CYSLTR1 (cysteinyl leukotriene 1 receptor)dCK (deoxycytidine kinase)DCKzeta (diacylglycerol kinase zeta)DHFR (Dihydrofolate reductase)DLL4DNADNA polymerase alphaDNA-PKDNMT (DNA methyltransferase)EDB (Extra Domain B of fibronectin)EF-2 (Elongation Factor 2)EGFREGFR (kinase)Endothelin BR (ETBR)ENPP1EP4 (prostaglandin E2 receptor subtype 4)EphA2ERERBB3(HER3)ERKERK1ERK1/2ERK2EZH1EZH1/2EZH2FAKFAP (fibroblast activation protein alpha)FAPalphaFASFascinFcγRIII (CD16)FcγRIIIa (CD16A)FGFRFGFR1FGFR1,3FGFR1-4FGFR2FGFR2,3FGFR2bFGFR3FGFR4FKBP-12FLT3FRalpha (Folate receptor 1)FSHR (Follicle Stimulating Hormone Receptor)Galectin-9Gamma-secretaseGlobo H (globohexaosylceramide)GlutaminaseGlycolipidsGlycoproteinsGPC3 (Glypican 3)GPER (G protein-coupled estrogen receptor)GRGrb2GREM1 (Gremlin1)Grp78GSPT1HDAC (Histone deacetylase)HDAC6 (histone deacetylase 6)HER2HER2 (kinase)HER4HIV proteaseHPK1 (hematopoietic progenitor kinase I)HRASHsc70HSF1 pathwayHsp70IAPIDH1IFNR alphaIGF-1RIKZFIKZF1IKZF3IL-10RIL-12RIL-15RIL-18RIL-2RIL-2R alphaIL-2R betaIL-2R/IL-15R beta/gammaIL-7RIL-8ILT2ILT3ILT4IRS1/2ItkJAKKAAG1KDM4Kir6/SUR2 channelKRASLabyrinthinLAG-3 (lymphocyte activation gene-3)LAIR-1 (CD305)latent TGFbeta1LckLSD1LysosomeMAGE-A4MALT-1MAT2A (methionine adenosyltransferase 2A)MCL1MCT (monocarboxylate transporter)MDMMDM2MDMXMEKMEK1MEK1/2MerMesothelinMethionineMETTL3MICAMICA/B (MHC class I chain-related protein A and B)MICBMitochondrial Hsp70MPS1 (TTK)mTORMUC16 (CA125)MUC1-CMYCNaPi2bNectin-4NeoantigensNF-kappaBNKG2ANOS (Nitric oxide synthase)NRASNTRK (Trk)NTRK1 (TrkA)NTRK1-3 (TrkA-C)NTRK2 (TrkB)NTRK3 (TrkC)NY-ESO-1ODC (ornithine decarboxylase)OX40p53_apan-CDKpan-PI3KPARPPARP1PARP1/2PARP1-3PARP7PCNAPD-1PDGFRPDGFR3PDGFRaPDGFRbPD-L1PGRN/GP88 (Progranulin)PI3KPI3K alphaPI3K betaPI3K gammaPI3K/mTORPKMYT1PLK-1Pol I (RNA polymerase I)PolQ (theta)Polyamine TransportPRAMEPRMT5proteasome-20SPTEF- bPTEF-b/CDK9PTPN2PVRPVRIGRAFRASRETRibonucleoprotein (RNP) complexRibosomeROR1ROSROS1RRM1(Ribonucleotide reductase)Sec61SHP2Sialyl Thomsen-nouveau (STn)SIKSIK2SIK3SIRPalpha (CD172a)SMARCA2SmoothenedSodium Potassium PumpSOS1SRCSRC family kinasesST2 (IL1RL1)STAT3STINGSurvivinTACTILETAG72 (tumor-associated glycoprotein 72)Tankyrase 1/2TEADTGFbetaTGFbeta1TGFbetaR1TIE-2TIGITTIM-3Tissue FactorTLRTLR3TLR7TLR7/8TLR8TLR9TNFalphaTOPO ITOPO II (TOP2A)TORCTORC1TRAILR2 (DR5)TREM1TREM2TROP2 [EGP-1 (epithelial glycoprotein-1)]TRPV6 calcium channelTS (Thymidylate synthase)TubulinTumor Associated AntigensULKULK1ULK1/2ULK2UndisclosedUSP1 (ubiquitin-specific protease inhibitor 1)VEGFVEGFRVEGFR1,2,3VEGFR2VEGFR2/3VEGFR3VISTAWEE1WT1 Other Common Drug Names: No preference No preference14-Hydroxydaunomycin2-difluoromethylornithine hydrochloride2-F-ara-AMP2X-1215-aza-4'-Thio-2'-Deoxycytidine8394A genetically modified oncolytic viral strain of the herpes simplex type 1 (HSV-1) virusA humanized anti-B7-H3 antibody conjugated to the vc- seco - DUocarmycin-hydroxyBenzamide-Azaindole (DUBA) 2 DNA alkylating payloadA2A receptor antagonist EOS100850AB122ABI-007ABI-009Abiplatin ABL111AbraxaneABT-0199ABT-888AccolateACT50actinium Ac 225 vofatamabAd5/3-E2F-d24-hTNFa-IRES-hIL2ADC DS-8201aado trastuzumab emtansineAF802Afatinib dimaleateAfinitorAG-013736AG-014699AG-120AGEN1181AGEN1777AGEN2034agonistic anti-OX40 monoclonal antibody INCAGN01949AK-01AKR1C3-activated prodrug OBI-3424Akt Inhibitor GDC-0068AKT/ERK inhibitor ONC201AL3818AlecensaAlimtaALK inhibitor CH5424802ALK/ROS1/NTRK/SRC multi-kinase inhibitor TPX-0005ALKS4230ALT-803ALX148AMG 510AMN 107AMX513 dicaprateAN0025AN2025anaplastic lymphoma kinase inhibitor CH5424802ANB011Anti programmed death ligand 1 monoclonal antibodyAnti-B7H1 Monoclonal Antibody MEDI4736anti-CCR8 monoclonal antibody LM-108anti-CD137 agonistic monoclonal antibody ADG106anti-CD137 agonistic monoclonal antibody LVGN6051anti-CD205 antibody-drug conjugate OBT076anti-CD27 monoclonal antibody GEN1053/BNT313anti-CD32B monoclonal antibody BI-1206anti-CD96 monoclonal antibody GSK6097608anti-CEA/Anti-4-1BB bispecific antibody BGB-B167anti-claudin 18.2 antibody-drug conjugate LM-302anti-CLDN6/CD3 BiTE antibody AMG 794anti-Clever-1 mAbanti-CTLA4 human monoclonal antibody CP-675,206anti-CTLA-4 monoclonal antibody ADG126anti-CTLA-4 monoclonal antibody AGEN1181anti-CTLA-4 probody BMS-986288anti-CTLA-4 SAFEbody ADG126Anti-Cytotoxic T-Lymphocyte-Associated Antigen-4 Monoclonal Antibodyanti-DLL4/VEGF bispecific monoclonal antibody OMP-305B83Anti-EGFR Monoclonal AntibodyAnti-erbB2 Monoclonal Antibodyanti-FGFR2 monoclonal antibody FPA144anti-folate receptor-alpha antibody drug conjugate STRO-002Anti-FOLR1-mab Maytansinoid Conjugateanti-globo H/MMAE antibody-drug conjugate OBI 999anti-HER2 ADC DS-8201aanti-HER2 antibody-drug conjugate DS-8201aanti-HER2 bi-specific monoclonal antibody ZW25anti-HER2 CAR macrophagesanti-HER2 x anti-CD3 bispecific monoclonal antibody BTRC 4017Aanti-HER2/Anti-HER3 bispecific monoclonal antibody MCLA-128anti-hFcγRIIB monoclonal antibody BI-1206anti-IL-8 monoclonal antibody HuMax-IL8anti-ILT2/anti-ILT4 monoclonal antibody NGM707anti-ILT4 monoclonal antibody MK-4830Anti-LAG-3 monoclonal antibody BMS-986016anti-LAG-3 monoclonal antibody LBL-007anti-latent TGF-beta 1 monoclonal antibody SRK-181anti-LILRB4 monoclonal antibody IO-202anti-MUC16/CD3 bispecific antibody REGN4018Anti-PD-1 human mab MDX-1106anti-PD-1 monoclonal antibody AB122anti-PD1 monoclonal antibody AGEN2034anti-PD-1 monoclonal antibody AMG 404anti-PD-1 monoclonal antibody BGB-A317anti-PD-1 monoclonal antibody BI 754091anti-PD-1 monoclonal antibody MGA012anti-PD-1 monoclonal antibody PDR001anti-PD-1 monoclonal antibody REGN2810anti-PD-1 monoclonal antibody TSR-042anti-PD-1/anti-CTLA-4 DART protein MGD019anti-PD1/CTLA4 bispecific antibody XmAb20717Anti-PD-L1Anti-PD-L1 Monoclonal Antibody MPDL3280A anti-PD-L1/4-1BB bispecific antibody ATG-101anti-PD-L1/4-1BB bispecific antibody INBRX-105anti-PD-L1/anti-4-1BB bispecific antibody ABL503anti-PVR monoclonal antibody NTX-1088anti-TIGIT monoclonal antibody SGN-TGTanti-TIGIT OMP-313M32anti-TROP-2 Antibody-Drug Conjugate IMMU-132Anti-TROP2/DXd antibody-drug conjugate DS-1062aanti-VEGF monoclonal antibodyAnzataxAP160APG-2575APL-101APL-2ArimidexARRY-067ARRY-162ARRY-438162ARRY-440ARRY-558aryl hydrocarbon receptor antagonist BAY2416964AS703026ASN007AsotaxATR kinase inhibitor AZD6738ATR kinase inhibitor BAY1895344ATR kinase inhibitor M1774ATR kinase inhibitor VX-970AtvogenAUR102Aurora A kinase inhibitor JAB-2485Aurora kinase A/B inhibitor TT-00420autologous aDC1-induced CTLsautologous anti-mesothelin T-cell receptor fusion construct T cells TC-210autologous anti-MUC16 CAR-mbIL15-HER1t T cells PRGN-3005autologous CAR-mbIL15-safety switch T cells PRGN-3007autologous CD30CAR-CD28-CD3zeta-expressing T lymphocytesautologous cytokine-induced killer cells/vaccinia virus DD-CDSR CRX100autologous genetically-modified MAGE-A4 C1032 CD8alpha T cellsautologous memory cytokine-enriched natural killer cellsAutologous Natural Killer Cell-like nCTLsautologous natural killer-like cytotoxic lymphocytesAutologous NK cellsautologous PBLs retrovirally-transduced with TCRs targeting neoantigensautologous TBX-4000-treated peripheral blood mononuclear cells TBX-3400autologous TCR-engineered T cells IMA203Autologous Tumor Infiltrating Lymphocytes LN-145-S1AV-951AvastinAZD2171AZD2281AZD6474AZD6738B1939 mesylateB43.13BA3071BavencioBAY 80-6946BAY1251152BAY1895344BAY73-4506Bcl-2 inhibitor APG 2575Bcl-2 inhibitor GDC-0199BemaciclibBeneflurBET bromodomain inhibitor ZEN-3694BGB-283BGB-A317BGJ398BI 754091BIBW 2992 MA2BiovelbinBi-Sialidasebispecific CD80-lgG4Fc-IL-2v fusion protein GI-101BKM120Blastolem BMN-673BMS-354825BMS-907351BMS-936558BMS986016BMS-986253BNT142 RiboMab (mRNA-encoded antibody)BP1001-ABRAF inhibitor GSK2118436BRAF inhibitor PLX8394BRAF/EGFR inhibitor BGB-283BRD4 protein degrader RNK05047Briplatin BristaxolBT5528 - an EphA2-targeting Bicycle Toxin ConjugateBT5528-100BT8009 - a Nectin-4-targeting Bicycle Toxin ConjugateBT8009-100BTRC 4017ABTX A51BusulfexbusulphanB-VaxxBYL719C3-targeted complement inhibitor APL-2CabometyxCACPCampothecin-11CamptoCamptosarCAPECaprelsaCarloxanCatequentinibCBT-101CCI-779CD47 antagonist ALX-148CD47/SIRPa-blocking agent ALX148CD4BCDA inhibitor E7727/decitabine combination agent ASTX727CDDPCDK inhibitor SCH 727965CDK2/5/9 inhibitor CYC065CDK4/6 Dual Inhibitor LY2835219CDK4/6 Inhibitor LEE011Cediranib maleateCerticanCF33-hNIS (hNIS - human sodium iodide symporter)CH5126766checkpoint kinase 1 inhibitor LY2606368Chimeric MoAb C225CiclofosfamidaCiclofosfamideCicloxalcis-DDPcis-platinumCisplatyl Citoplatino Citosin CK1alpha/CDK7/CDK9 inhibitor BTX-A51CKI27ClafenClapheneClevegenClofarexClolarClostridium novyi-NT sporesCM-24c-met/HGFR tyrosine kinase inhibitor PF-02341066CO-338Cometriqconditionally active biologic anti-CTLA4 antibody BA3071CORT125134Cotellic CP monohydrateCP-675CP-675,206CP-675206CPI-0209CPMCRM1 nuclear export inhibitor KPT-330CRX-100CX-5461CYC065CycloblastinCycloblastineCYCLO-cellCyclophosphamCyclophosphamid monohydrateCyclophosphamidumCyclophosphanCyclophosphanumCyclostinCyclostineCytophosphanCytophosphanecytotoxic lymphocyte maturation factor interleukin-12CytoxanDAB389 interleukin-2 immunotoxinDacotinDacplatDato-DXdDAY101DepaconDepakeneDFMODNA Damage Response InhibitorDNA-PK inhibitor MSC2490484ADocetaxel Nanoparticle Formulated with Human AlbuminDoxilDox-SLDPX-SurvivacDS-3032bDS-8201DS-8201aDual Innate Immune Activator SYNB1891dual PI3 kinase/mTOR inhibitor PKI-587E7080E7389E7449E7777EchopulseEdodekin alfaEGEN-001EGFR/HER2 inhibitor ORIC-114EloxatinEloxatineEMD 1036239enadenotucirev-expressing anti-CD40 agonistic monoclonal antibody NG-350enadenotucirev-expressing FAP/CD3 bispecific FAP-TAc NG-641endothelin B receptor blocker ENB 003EndoxanEndoxanaEnduxanengineered toxin body-targeting HER2 MT-5111ENV-101EOS-850EP4 antagonist INV-1120epipodophyllotoxinER-086526ER-203492-00ErbituxErivedgeERK 1/2 inhibitor ASTX029ERK1/2 inhibitor ERAS-007EunadesEvacetEZH2 inhibitor CPI-0209fam-trastuzumab deruxtecan-nxkiFaslodexFc-engineered anti-CD40 agonist antibody 2141-V11FemaraFGFR inhibitor TAS-120 Fludara OralFollicle Stimulating Hormone Receptor T CellsFortametFosfaseronFP-1305FPA144FUSAG protein-coupled estrogen receptor agonist LNS8801gamma secretase inhibitor PF-03084014GDC-0068GDC-0077GDC-0084GDC-0199GDC-0449GDC-0973GDC-9545GemzarGenoxalGilotrifGL-ONC1GLS-010GlucophageGlumetzaglutaminase inhibitor IPN60090GLV-1h68GSK1120212GSK2110183GSK2118436GSK-2118436AGSK572016GW2016GX-I7hafnium oxide-containing nanoparticles NBTXR3Halavenhalichrondrin B analogHDAC inhibitor CRA-024781HDAC inhibitor SNDX-275Hedgehog antagonist GDC-0449HER2 Monoclonal AntibodyHER2 tri-specific natural killer cell engager DF1001HerceptinhetIL-15HiltonolHKI-272HOV2hrS7-SN38 antibody drug conjugatehuman interleukin-7 mRNA-encoded BNT152HycamptamineHycamtinHydroxyl-DaunorubicinHyleukinHyperthermic Intraperitoneal ChemotherapyIACS-15509IbranceICI 182,780ICON-2ICP-192IL-15/IL-15 receptor alpha sushi+ domain fusion protein SO-C101IL15/IL15R alpha heterodimeric Fc-fusionsIL15/sIL-15R alphaIL-2/Anti-IL-2 antibody conjugate SLC-3010IMC-F106C, a T cell redirecting bi-specific biologicImfinziIMGN853immunoglobulin G1 (human-mouse monoclonal rhuMab-VEGF gamma-chainIMNN-001INCMGA00012INK-1117InlytaInterleukin-15 fusion protein BJ-001interleukin-15/interleukin-15 receptor alpha complex-Fc fusion protein XmAb24306interleukin-15/interleukin-15 receptor alpha sushi+ domain fusion protein SO-C101intermediate-affinity interleukin-2 receptor agonist ALKS 4230IPN60090iPSC-derived CD16/IL-15RF-expressing CD38-eliminated NK Cells FT538IrbinitinibIrradiationJNJ-61610588JS001JTP-74057JTX-1811KadcylaKDM4 inhibitor TACH101KeytrudaKisqaliKPT-330KRAS G12C inhibitor MRTX849KRAS mutant-targeting AMG 510KRAS-MAPK signaling pathway inhibitor JAB-3312LAIR-2 fusion protein NC410Lambrolizumablapatinib ditosylateLastetLederplatin LedoxinaLEE011LenvimaLGX818LibtayoLifirfeniblight-emitting oncolytic vaccinia virus GL-ONC1LipoDoxliposomal doxorubicinLM-302LOXO-101LOXO-292LY2606368LY2853219LY2940680LY3214996LynparzaM1774M3814M6620M7824M9346A-sulfo-SPDB-DM4MCLA-128MDL 71782MDM2 antagonist RO5503781MDM2/MDMX inhibitor ALRN-6924MDV3800MDX 018MDX-010MDX-1106MEDI4736MEK Inhibitor GSK1120212MEK inhibitor MEK162MEK inhibitor PD0325901MEK162MekinistMektoviMEN 1309metal-organic framework (MOF) compound RiMO-301Metaplatin MethazolastoneMGA012MGC018MGD019microbiome GEN-001Milademetan tosylateMitoxanMK-2140MK3475MK-3475MK4827MK-6018MK-7902ML-246MLN1117MOF compound RiMO-301monoclonal antibody 2C4Monoclonal Antibody B43.13monoclonal antibody TRK-950MORAb-202MPDL3280AMPS1 inhibitor CFI-402257MRTX849MS 275MSB0010718CMSB0011359CMSC1936369BMTIG7192Amultikinase inhibitor BAY 73-4506multi-kinase inhibitor TPX-0022multi-kinase inhibitor TT-00420multi-kinase inhibitor XL092myleranN-803Nab-paclitaxel/danburstotug complex AP160nab-rapamycinNanoparticle Albumin-Bound RapamycinNanoparticle Albumin-Bound Sirolimusnatural killer cell stimulatory factor NM-IL-12NavelbineNavelbine ditartrateNCE401NemvaleukinNeoplatin NeosarNovoplatinumNovoTTF-100L(O)NSC 726189NT-I7NUV-655NVBNVP-BKM120OHPOMP-305B83OMP-313M32oncolytic adenoviral vector-expressing anti-CD40 agonistic antibodyoncolytic herpes simplex virus-1 expressing anti-CTLA-4 antibody/CD40L/4-1BBL RP3oncolytic HSV-1-expressing IL-12 and anti-PD-1 antibody T3011oncolytic measles virus encoding thyroidal sodium iodide symporteroncolytic virus RP1ONO-4538ONT-380OpdivoOvaRexPaclitaxel Albumin-Stabilized Nanoparticle FormulaPaclitaxel-loaded tumor penetrating microparticlespan FGFR Kinase Inhibitor BGJ398 pan-FGFR tyrosine kinase inhibitor JNJ-42756493pan-RAF kinase inhibitor DAY101ParaplatinPARP inhibitor BGB-290PARP/Tankyrase inhibitor 2X-121PCI-24781PD-0325901PD0332991PD-0332991PD-1 selected TIL therapyPD272PDR001PEG-PEI-cholesterol lipopolymer-encased IL-12 DNA plasmid vector GEN-1Pegtomarginasepegylated deoxycytidine analogue DFP-14927Pegylated Liposomal Doxorubicin Hydrochloridepegylated recombinant IL-2 variant THOR-707pegylated SN-38 conjugate PLX038Pemetrexed disodiumPeposertibPerjetapertuzumab, trastuzumab, and hyaluronidase-zzxfPF 01367338PF-02341066PF-03084014PF-04554878PF-05212384PF-06463922PGE2 receptor antagonist INV-1120PH20 hyaluronidase-expressing adenovirus VCN-01phIL-12-005/PPCphosphoinositide 3-Kinase inhibitor BYL719PI3K alpha inhibitor MLN1117PI3K inhibitor BAY 80-6946PI3K inhibitor BYL719PI3K inhibitor GDC-0084PiqrayPKI-587PlacisPlaquenilPlatamine Platiblastin Platiblastin-S Platinex PlatinolPlatiranPlatistinPlatosinPLX4032Pol I inhibitor CX5461poly I:poly C with poly-1-lysine stabilizerpolyamine transport inhibitor AMXT-1501 dicapratepoly-ICLCPolyinosinic-Polycytidylic Acid Stabilized with Polylysine and CarboxymethylcellulosePraxelpressurized intraperitoneal aerosol chemotherapyPrexasertibProcytoxprostaglandin E2 EP4 receptor inhibitor E7046protein-engineered interleukin-2 XTX202PS-341PTEF-b/CDK9 inhibitor VIP152PTPN11 inhibitor RMC-4630PXD101RAD001RadiotherapyRaf Kinase Inhibitor LGX818Raf/MEK dual kinase inhibitor RO5126766RAIN-32RapamuneRapamycinRAS inhibitor RMC-6236Ras-selective tri-complex inhibitor RMC-6236Recentinrecombinant human IL-7-hybrid Fc NT-I7recombinant interleukin-12REGN2810REGN4018RELARET inhibitor EP0031RET kinase inhibitor LOXO-292RetevmoRG6114RG7388RG7440RG7446RG7601RG7666rhuMAb2C4ribocytokine IL-7 BNT152RiometRLI 15RLY-1971RMI-71782RNA Pol I inhibitor CX5461Ro 24-7472RO5126766RO5185426RO5503781RO7092284RozlytrekRP-3500RTK inhibitor TKI258RubracaRXDX-101Salmonella enterica serotype typhimurium expressing L-methioninase SGN1SAR442720SCH 727965SCH 900475selective estrogen receptor downregulator GDC-9545selective inhibitor of nuclear export KPT-330SendoxanSGN TGTSHP2 inhibitor RMC-4630SHP2 inhibitor TNO155SIRPaFcSmac mimetic BGB-24714Smac Mimetic TL32711SNDX-275SNDX-6352SO-C101SOT101SotorasibSPEAR T-cell ADP-A2M4CD8SprycelSRF813StavzorSTING agonist GSK3745417StivargaSTRO-002Sunitinib malatesuperagonist interleukin-15:interleukin-15 receptor alphaSu/Fc fusion complex N-803survivin antigen vaccine DPX-SurvivacSutentSyklofosfamidTAB-001TAB004TafinlarTAK-117TAK-580Talazoparib Tosylate TalzennaTarcevaTAS-120TasignaTaxolTaxol KonzentratTaxotereTC-210 T cellsTC-210 TruC-T cellsTCApFT-DM1T-DxdTecentriqTemodalTemodarTH 3424THOR-707threonine tyrosine kinase inhibitor CFI-402257TIC10TicilimumabTJ033721TJ107TJ-L14BTL32711TMT212TNFalpha/IL-2-encoding oncolytic adenovirus TILT-123TOPOToposarToriselTPX-0005TPX-0022trastuzumab-DM1trastuzumab-MCC-DM1trastuzumab-MCC-DM1 antibody-drug conjugatetrastuzumab-MCC-DM1 immunoconjugateTRC102triptolide analogueTrk inhibitor LOXO-101TrkA inhibitor VMD-928TrkA/B/C/ROS1/ALK tyrosine kinase inhibitor RXDX-101TrodelvyTRPV6 calcium channel inhibitor SOR-C13TSR-042TTK inhibitor CFI-402257tumor-cells apoptosis factor hormone-peptideTXLTykerbUpRiValproate VaniqaVAXINIAVE-822VebreltinibVelcadeVePesidVerzenioVinorelbine ditartrateVinorelbine tartrateViraceptVitrakviVLS-101VNBVotrientVS-6063VS-6766VX-803VX-970WT1-targeted IL-2-based fusion protein CUE-102XalkoriXelodaXL184XL518XmAb20717XmAb717XMT-1536XpovioYervoyZactimaZD6474ZD9238ZejulaZelborafZEN003694ZN-c3ZortressZW25ZW49Zytoxan Tumor Genomic Alteration: selectABL1AKT1AKT2AKT2 AMPAKT3ALKALK AMPARID1AATMATRATRXAXLBAP1BARD1Bcr-ablBLMBRAFBRAF V600BRAF V600EBRIP1CCND1 AMPCCND2 AMPCCND3 AMPCCNE1 AMPCD274 (PD-L1)CDK12CDK4 AMPCDK6 AMPCDKN2ACHEK1CHEK2cKITCREBBPCSF1RCTNNB1DDR2EGFR EGFR AMPEIF1AXEMSY AMPEP300EPHA2ERBB2 (aka HER2)ERBB2 AMPERBB3 (aka HER3)ERBB3 AMPERBB4 (aka HER4)ERCC1ERCC2FAM175AFANCA FANCA AMPFANCC FANCC AMPFANCD2 FANCD2 AMPFANCE FANCE AMPFANCFFANCGFANCLFBXW7FGFFGFR1 FGFR1 AMPFGFR2 FGFR2 AMPFGFR3 FGFR3 AMPFGFR4FGFR4 AMPFLT3FYNGNA11GNAQHRASIDH1IDH2KDRKDR AMPKEAP1KITKIT AMPKRAS KRAS AMPLCKLKB1LYNMAP2K1MAP2K2MDM4MDM2MET MET AMPMLH1MLL2MRE11AMSH2MSH6mTORMTAPMYC AMPMYCL AMPMYCN AMPNBNNF1NF2NRASNFE2L2NRG1NTRK1NTRK2NTRK3PALB2PARP1PARP2PDGFRPDGFRAPDGFRA AMPPDGFRBPIK3CA PIK3CA AMPPIK3CB AMPPIK3CB PIK3R1PMS2POLD1POLEPOLQPRKDCPPP2R2APTCH1PTENRAD50RAD51RAD51BRAD51CRAD51DRAD54LRB1RAF1RETRNF43ROS1RSPOSETD2SLX4SF3B1SMARCB1SMARCA4SMOSRCSRSF2TIPARP AMPTORC1TORC2TP53TRKTSC1TSC2VEGFRU2AF1WRNXRCCYES1ZRSR2 Return only trials with results Include all Phase 1 trials (i.e., dose-finding as well as expansion) Criteria Arm: All All12345 Matching Trials Save Trials For more detailed information please click on the clinical trial number and you will be taken to the clinicaltrials.gov website. For a key to the icons and text used in the Results column, please click here. To learn more about our trial annotation process, results assignments, and the criteria used to highlight drugs with promising results, please click here. Clinical Trial Phase Eligible Participant Official Title Location Drugs in Trial Results NCT03735589I/IINewly diagnosed stage II-IV ovarian cancer that responded to first-line platinum therapyA Phase I/IIa Safety and Immunologic Efficacy Trial of Intraperitoneal Induction of CTLs Combined With Alpha-Dendritic Cell Vaccine for Primary Ovarian CancerNYView Drugs Drug(s) in Trial Other Drug Names Main Known Action Drug Status Alpha-DC1 vaccineImmune response against tumor-associated antigensClinical TrialsAutologous nCTLsAutologous Natural Killer Cell-like nCTLs, autologous natural killer-like cytotoxic lymphocytes, autologous aDC1-induced CTLsAnti-tumor immune responseClinical Trials NCT03832855IAdvanced HER3+ tumors with complete response after surgery and chemotherapyAssessing the Immunogenicity of pING-hHER3FL in Patients With Resected MalignanciesNCView Drugs Drug(s) in Trial Other Drug Names Main Known Action Drug Status pING-hHER3FLimmune response against cancer expressing ERBB3(HER3)Clinical Trials If you have any questions or would like help with your search, please call us at: 858-657-0282 or email us at patientsupport@clearityfoundation.org. × If you have any questions or would like help with your search, please call us at: 858-657-0282 or email us at patientsupport@clearityfoundation.org. × Results for ovarian cancer patients in the same or similar trial Promising results for ovarian cancer patients in the same or similar trial Results for a small number of ovarian cancer patients in the same or similar trial Promising results for a small number of ovarian cancer patients in the same or similar trial Results for patients with other cancer types in the same trial View Results Results for ovarian cancer patients in a different trial with same or similar drugs View Results Promising results for ovarian cancer patients in a different trial with same or similar drugs View Results Results for patients with other cancer types